Posted by Michael Wonder on 13 Jul 2020
EUnetHTA is extended for one year and focuses on COVID-19
9 July 2020 - The European project EUnetHTA, in which TLV, SBU and the Swedish Medicines Agency are Swedish partners, has been granted an extension with a fifth project year.
The project will now end on 31 May 2021.
TLV's chief pharmacist Niklas Hedberg remains chairman of the EUnetHTA Executive Board during the extension.
